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Article Highlights 
• Stem cells and scaffolds - an essential role in the production of new tissue by tissue 
engineering 
• Nanotechnology - a field of high importance and rapid development 
• Functional necessities of scaffolds – biocompatibility, biodegradability and mechanical 
properties 
• The main challenge: transforming tissue engineering into regenerative engineering 
 
Abstract 
Millions of patients worldwide need surgery to repair or replace tissue that has 
been damaged through trauma or disease. To solve the problem of lost tissue, 
a major emphasis of tissue engineering (TE) is on tissue regeneration. Stem 
cells and highly porous biomaterials used as cell carriers (scaffolds) have an 
essential role in the production of new tissue by TE. The cellular component is 
important for the generation and establishment of the extracellular matrix, 
while a scaffold is necessary to determine the shape of the newly formed tis-
sue and facilitate migration of cells into the desired location, as well as their 
growth and differentiation. This review describes the types, characteristics and 
classification of stem cells. Furthermore, it includes functional features of cell 
carriers – biocompatibility, biodegradability and mechanical properties of bio-
materials used in developing state-of-the-art scaffolds for TE applications, as 
well as suitability for different tissues. Moreover, it explains the importance of 
nanotechnology and defines the challenges and the purpose of future research 
in this rapidly advancing field. 





Millions of patients worldwide need surgical 
procedures to repair or replace tissue that has been 
damaged through trauma or disease [1]. Today, con-
ventional therapy addresses the problem of lost tissue 
by appropriate tissue replacement – tissue graft. The 
majority of defects can be healed using standard con-
servative or surgical methods. However, large defects 
occurring after tumor surgery, cysts or multiple frac-
                                                 
Correspondence: I. Karadzic, Centre of Research Excellence in 
Nutrition and Metabolism, Institute for Medical Research, Uni-
versity of Belgrade, Tadeusa Koscuska 1, P.O. Box 102, 11129 
Belgrade, Serbia. 
E-mail: ivana.colak@gmail.com 
Paper received: 31 December, 2014 
Paper revised: 11 May, 2015 
Paper accepted: 21 July, 2015 
* This paper was part of a plenary lecture at the Rosov Pin 
Conference 2014. 
tures require a more complex procedure of tissue rep-
aration [2,3]. 
With respect to lost tissue treatment, the main 
emphasis of tissue engineering is on tissue regener-
ation (TE) rather than tissue replacement [4–7]. Thus, 
stem cells and highly porous biomaterials used as 
scaffolds have an essential role in the production of 
new tissue by TE (Figure 1). The cellular component 
is important for the generation and establishment of 
extracellular matrix (ECM) in the new tissue, while a 
scaffold is necessary for providing mechanical stab-
ility and foundation for a new three-dimensional tissue 
structure [6,8,9]. 
Since it has been demonstrated that biological 
systems correspond better to nano- than micro-dim-
ensional biomaterial structures, nanotechnology has 
become a field of high importance and rapid develop-
ment [10–12]. Also, composition, size, morphology 
and geometry of nanostructured materials can be 
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controlled. Further, the surface of these materials can 
be modified in order to enhance biocompatibility, 
immune compatibility and/or cell adhesion [13]. 
This review describes the functional necessities 
and types of stem cells and biomaterials used in dev-
eloping state-of-the-art scaffolds for tissue engineer-
ing applications. Furthermore, it defines the chal-
lenges and the purpose of future research in this fast 
advancing field. 
Stem cells and tissue engineering 
Stem cells are unspecialized cells in the early 
stage of the development, which under normal con-
ditions have the ability to differentiate into specialized 
mature cells and to divide in order to produce more 
stem cells [14–17]. Two functions define stem cells: 
unlimited self-renewal capacity, which makes them 
potentially immortal, and pluripotency [18]. Stem cells 
can be divided in several different ways, as shown in 
Table 1 [15,19–22]. 
Although they have less ability to differentiate, 
adult stem cells are far more applicable in regener-
ative medicine than embryonic stem cells, primarily 
because of being relatively easy to isolate, lack of 
oncogenic potential and no ethical constraints over 
their application [23–26]. 
Architecture and nanotechnology of scaffolds 
The ECM represents a biological 3D carrier for 
the cells and provides appropriate environment and 
architecture specific for each tissue [27]. Therefore, 
the key to a successful TE is proper design of cell 
carriers – scaffolds, which mimic the native ECM, 
combined with adequate stem cells. The role of these 
carriers is to determine the shape of the newly formed 
tissue and facilitate the migration of cells into the des-
ired location, their growth and differentiation [28,29]. 
The key characteristic of every scaffold is that it 
must be biocompatible – to provide physical and 
mechanical functions and provoke a preferred res-
ponse without causing any undesirable reactions in 
the host. Hence, the choice of material is a crucial 
point in tissue engineering [28,30]. It is desirable for 
the scaffold to disintegrate during the formation of 
new tissue, to allow the body’s own cells, over time, to 
eventually replace the implanted material [31]. There-
fore, the biodegradability of the scaffold is also con-
sidered very important in these processes. 
Developing scaffolds with adequate mechanical 
properties is one of the greatest challenges in 
attempting to engineer bone or cartilage [32,33]. A 
balance must be achieved between the mechanical 
 
Figure 1. Basic concept of tissue engineering. 
Table 1. Stem cells classification according to different criteria 
Criterion Stem cells type Properties 
Cell potency Totipotent stem cells 
Pluripotent stem cells 
Multipotent stem cells 
Unipotent stem cells 
Potential to differentiate in any human cell even whole organism 
Potential to differentiate in various tissue types but not whole organism 
Potential to differentiate in various cell types within tissue – progenitor cell 
Potential to differentiate in one cell type – precursor cell 
Function Normal stem cells 
Cancer stem cells 
Not involved in pathologic process 
Associated with most cancer disease 
Sources Embryonic stem cells 
Adult stem cells 
Derived from inner cell mass of blastocyst 
Derived from endoderm, mesoderm or ectoderm 
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properties and a sufficiently porous architecture in 
order to obtain the desired scaffold [34]. Adequate 
porosity allows cell migration and provides a suitable 
microenvironment for cell proliferation and differen-
tiation, with adequate vascularization, flow of nut-
rients and oxygen and elimination of degradation 
products [35–37]. The porosity should be in the opti-
mal range: small enough to ensure mechanical integ-
rity and sufficiently large to provide optimal bioactivity. 
For this reason, the size of the pores should be less 
than 300 nm [29]. 
Two types of materials are currently used in TE: 
natural and synthetic [38]. The advantage of natural 
materials is biological recognition regarding cell adhe-
sion and function. However, the downsides are 
uncontrolled mechanical properties and biodegrad-
ability, possible host immune reaction and the cost 
[39,40]. Various natural materials have been eval-
uated to date. Derivatives of ECM have been inves-
tigated for supporting cell growth. Proteins collagen 
and fibrin, as well as polysaccharides glycosam-
inoglycans, have all proved appropriate regarding cell 
compatibility, but some potential immunogenic issues 
still remain [35,41,42]. Hyaluronic acid, one of the 
most exploited glycosaminoglycans, in combination 
with glutaraldehyde or water soluble carbodiimide, is 
considered suitable for scaffold materials [43]. Poly-
saccharide chitin and chitosan based nanofibers have 
remarkable potential to be used as tissue engineering 
scaffolds, as well as drug delivery systems, wound 
dressing materials, antimicrobial agents and biosen-
sors, due to their biocompatibility, biodegradability, 
antibacterial activity, low immunogenicity, wound 
healing capacity and cell binding capability [44]. 
Further, some scaffolds are tested for use in the deli-
very of small molecules (drugs) to specific tissues 
[45]. Finally, decellularized tissue extracts in which 
the remaining cellular residues or ECM act as a scaf-
fold, are another form of cell carriers undergoing inv-
estigation [46]. 
Synthetic materials, on the other hand, have the 
advantage of a commercial production, together with 
a control over mechanical properties, microstructure 
and degradation rate.  
A commonly used synthetic material is polylactic 
acid (PLA). This is a polyester which degrades within 
the human body to form lactic acid, a chemical com-
pound that plays a role in various biochemical pro-
cesses and is easily removed from the body. The 
nanofibrous PLA mats incorporating carbon nano-
tubes and rectorite, fabricated using an electrospin-
ning technique, have proven suitable for biomedical 
applications due to their increased thermal stability 
and low cytotoxicity [47]. Similar to PLA are polygly-
colic acid (PGA), polylactic-co-glycolic acid (PLGA) 
and polycaprolactone (PCL), with degradation mech-
anisms similar to that of PLA but a different rate of 
degradation compared to PLA [48,49]. Other natural 
and synthetic materials have also been used in scaf-
fold synthesis (Figure 2).  
Due to their unique chemical, physical and bio-
logical functions, nano-sized particles/fillers, of both 
inorganic and organic origin, have been studied in 
detail. They differ in their structure, composition, 
design and application, and can be in the form of 
nanofibers, nanogels, etc, as presented in Figure 2. 
Nanocomposite hydrogels combine the advantages of 
nano-fillers and hydrogel matrices and thus may 
result in improved mechanical and biological proper-
ties and find their potential application in biomedicine 
as drug delivery matrices and scaffolds [50]. Rec-
ently, injectable scaffolds have received attention due 
to their potential for avoiding the invasive surgery 
normally required for tissue implantation. Natural 
 
Figure 2. Synthesis, structure and design of different forms of nanomaterials used as scaffolds in tissue engineering. 
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polymers chitosan and alginate are used as coating 
materials to make positively and negatively charged 
PLGA nanoparticles, respectively. All the results 
demonstrate the potential use of the biodegradable 
colloidal gels as injectable scaffolds in tissue eng-
ineering and drug release [51]. 
Application of scaffolds in tissue engineering 
Bone disease or bone defects such as osteosar-
coma, osteoporosis, and bone fractures affect millions 
of individuals worldwide [1]. In order to solve the prob-
lem of lost bone tissue, bone tissue engineering 
emphasizes tissue regeneration rather than tissue 
replacement and is becoming a subject of growing 
interest. For over two decades, bioceramic material – 
hydroxyapatite (HAP) has been used as a substitute 
for bone as it has physical properties similar to the 
inorganic component of natural bone [52]. It is suit-
able material for hard tissue replacement due to its 
osteoconductivity, biocompatibility and slow resorp-
tion. On the other hand, the porosity of hidroxyapatite 
translates into poor mechanical properties [53]. In the 
attempt to compensate for these disadvantages, var-
ious polymers have been examined, however, none 
of these meet all of the requirements for the ideal cell 
carrier in bone TE [54]. This has led to the develop-
ment of composite carriers consisting of both an 
inorganic and organic component where the inorganic 
particles are embedded into the surface of a polymer 
matrix [36,55]. Inorganic-organic composites are 
designed to mimic natural bone by combining the 
viscoelastic properties of polymers with the strength 
of the inorganic part of the composite, to create bio-
active materials with improved mechanical properties 
and ability to degrade over time [56]. Also, the basic 
products of decomposition of hydroxyapatite and tri-
calcium-phosphate neutralize the acidity of the poly-
meric compounds. Regarding higher bioactivity, 
inorganic nanostructured components have received 
more interest than equivalent microstructured ones 
[57]. Nanocomposites based on hydroxyapatite-col-
lagen are being particularly rapidly developed and 
showing promising results [58,59]. Recently, negat-
ively charged inorganic hydroxyapatite nanoparticles 
(NPs) and positively charged organic PLGA NPs were 
assembled to form a cohesive colloidal gel which 
proved to be suitable as an injectable filling for the 
purpose of bone tissue regeneration [60]. Further, in 
vivo tests revealed that a similar colloidal gel, created 
by mixing PLGA nanoparticles of opposite charge, 
capable of controlled release, has shown good results 
as a filler for repair of cranial bone defects [61]. Use 
of a composite scaffold with high porosity (low mech-
anical properties) and fast degradation kinetics has 
led to the production of grafts that can be used in low 
load sites. In the middle of the last decade, a unique 
composite carrier consising of a combination of bio-
degradable PLGA and bioresorbable calcium phos-
phate cement was created. This carrier is charact-
erized by high porosity (81–91%), with macropores of 
0.8–1.8 mm, and improved mechanical properties due 
to the polymer [62]. Another 3D scaffold suitable for 
bone regeneration, with porous design and mech-
anical properties similar to the trabecular bone is 
obtained by combining calcium phosphate ceramics 
(low crystalline CaP) fused in biodegradable PLGA 
microspheres [63]. 
Scaffolds are commonly applied in bone and 
cartilage tissue engineering, although notable results 
have been achieved in many other tissues, including 
skin, nerves, heart etc. However, different tissues 
have their own peculiarities. For instance, skin tissue 
engineering is complex for various reasons: greatly 
limited donor sites in patients with skin losses over 
50–60%, transmission of infection (mostly human 
immunodeficiency virus or hepatitis related to allo-
geneic skin grafting), pain, and scarring at donor sites 
[64]. Several scaffolds have been investigated for 
applications in skin TE. In a rat model, regeneration of 
tissue with similar properties to the native dermis and 
significantly enhanced formation of blood capillaries 
has been achieved after a novel composite film of 
salmon DNA and collagen was implanted in a full-
thickness skin wound in the dorsal region [65]. Fur-
ther, alginate is also considered a promising agent in 
skin tissue engineering due to its ability to maintain a 
physiological, moist, microenvironment, reducing pos-
sibility for bacterial infection, and facilitating wound 
healing especially in deep-thickness wounds [66]. 
Polysaccharide chitin has been combined with other 
marine-derived composites and developed into a hyd-
rogel wound dressing, providing good moist healing 
environment and encouraging capillary formation in a 
full-thickness skin wound in rat [67]. Composite nano-
fibrous cellulose acetate 3D mat coated with posi-
tively charged lysozyme and negatively charged 
layered silicate – rectorite, obtained by electrospray-
ing, has shown promising results in pharmaceutical 
uses and antimicrobial wound dressing [68]. In addi-
tion, a nanofibrous scaffold made of PLGA-chito-
san/polyvinyl alcohol, fabricated by electrospinning, is 
proving to be useful in skin tissue engineering [42]. 
Recently, novel nanofibrous mats have been deve-
loped, coated layer-by-layer with silk fibroin and lyso-
zyme on a cellulose electrospun template via electro-
static interaction. These mats are promising tools in 
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dermal reconstruction due to their nontoxic, biodeg-
radable, biocompatible, antibacterial and wound heal-
ing properties [69]. 
In contrast, in cardiac tissue engineering the aim 
is to produce tissue constructs that are thick and com-
pact, contain physiological densities of metabolically 
active cardiac cells, and contract synchronously in 
response to electrical stimulation with sufficient force 
[70]. The most difficult requirements are probably 
related to the establishment of blood flow and to the 
integration and electromechanical coupling with the 
host tissue. Shinoka [71] presented the first results of 
tissue engineered heart valves implanted into the 
juvenile sheep model. The scaffolds used for these 
heart valves were created from biodegradable poly-
mers which were seeded in vitro with autologous 
valve cells. Recently, additional studies were per-
formed to examine tissue activity at the mitral site of 
the experimental model, allowing to assess the high-
est tissue stress that can be achieved by tissue eng-
ineered heart valves [72]. The next challenge is to 
insert these heart valves with minimally invasive tech-
nique without alteration of the tissue during the imp-
lantation. Finally, the field of the whole organ eng-
ineering has been expanding, in which the bio-arti-
ficial heart [73] could overcome the problem of organ 
deficiency for patients suffering from end-stage heart 
failure.  
In the case of cartilage produced for the auricle 
and nose or for complex facial trauma, the emphasis 
is on maintaining the shape and accurate repro-
duction of the intended geometry [74]. Also, it is very 
important to imitate the mechanical characteristics 
found in the native cartilage and to control the mech-
anical stimulus for chondrogenesis and ECM pro-
duction. Chen et al. [74] have shown that collagen in 
its natural form is a better surface modification mat-
erial than gelatin for promoting cell adhesion, prolifer-
ation and secretion of ECM components. Transplant-
ation of peptide hydrogels made of nanofiber scaf-
folds containing chondrocytes and growth factors, into 
cartilage defects in a bovine model, resulted in exten-
sive synthesis of glycosaminoglycans and type-II col-
lagen similar to the native cartilage [75]. In vitro exp-
eriments revealed that peptide scaffolds comprising 
growth factors are capable of inducing chondrogenic 
differentiation of human mesenchymal stem cells 
(MSCs). These scaffolds can promote substantial reg-
eneration of the articular cartilage in full thickness 
chondral microfractured defects in the trochlea of 
adult rabbits in the presence of bone marrow MSCs 
[76]. 
In nerve tissue engineering, due to the complex 
system, involving neural cells, the microenvironment 
with a variety of cell receptors, the ECM and specific 
chemo–physical properties, electrospun guidance 
channels and hydrogels are considered to be the 
most promising types of scaffolds [77]. The soft nat-
ure of the nervous tissue potentially makes hydrogels 
the ideal material, considering also their biodegrad-
ability, flexibility and low inflammatory potential. Ade-
quate matching between the mechanical properties of 
different materials and specific neural environments is 
crucial in achieving the correct morphology, neural 
growth and differentiation. It has been demonstrated 
that neurite extension in dorsal root ganglia cells 
conversely correlates with the mechanical stiffness of 
agarose gels [78]. Many natural and synthetic poly-
mers have been investigated for use as neural scaf-
fold materials. For example, a biodegradable glass 
material was used to repair the facial or median nerve 
in a sheep model [79] and carbon nanostructures, 
including nanotubes, nanofibers and graphene have 
been incorporated in some experimental neural pros-
theses and guides [80].  
Various types of tissues and their stem cells that 
are commonly used and described for application in 
tissue engineering are shown in Figure 3. 
 
Figure 3. Various types of adult stem cells used in tissue 
engineering: (a) skin, (b) ligaments and cartilage, (c) brain, 
(d) muscle, (e) bone and (f) cardiovascular. 
Examples of nanostructured scaffolds applied in bone 
TE 
One of the most frequently used polymers for 
composite scaffolds today is PLGA, primarily due to 
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its proven biocompatibility and a variable degradation 
rate that can be regulated by modifying the propor-
tions of its constituent polymers, PLA and PGA 
[2,5,81,82]. Moreover, the reversibility of a colloidal 
gel composed of oppositely charged PLGA nano-
particles makes it excellent material for molding, ext-
rusion or injection of tissue engineering scaffolds[83]. 
There are, also, newly developed materials based on 
PLGA/HAP composites that are interesting for TE 
because of their high biocompatibility and ability to 
mimic natural bone. These materials have become a 
promising tool in load-bearing bone TE, and might 
provide optimal cell differentiation and mineralization 
of the bone tissue. Cells seeded on such materials 
easily adhere, especially on hydroxyapatite surface, 
which indicates good cell proliferation and integration 
of the bone implants [84]. 
In order to obtain better characteristics of scaf-
folds, new materials and new scaffold producing tech-
niques are currently in development. Appropriate mor-
phology of scaffold walls can be attained by using 
nanodesign hydroxyapatite particles inside a biomim-
etic medium, where they self-assemble on a poly-
mer/ceramic scaffold structure [38]. It is an improve-
ment on design of scaffold obtained using polymeric 
foam template based in polyurethane. This biomim-
etic method has shown that it stimulates the growth of 
“bone-like” structures on scaffold surfaces [85]. In this 
way, nanodesigned biomimetic apatite is very similar 
to biological apatite and very suitable for cell growth 
and proliferation [8].  
A composite scaffold PLGA/HAP registered 
under the name ALBO-OSS has shown good cell 
adhesion of cells grown in control medium. Cells were 
spherical with clearly visible pseudopodia or cytoplas-
mic extensions (Figure 4a). After 7 days of culture in 
osteogenic medium, polygonal cells with very elong-
ated cytoplasmic extensions were detected. The org-
anic fibrous-like structures have also been observed 
(Figure 4b). These structures and cell morphology are 
typical for stem cells undergoing osteogenic differ-
entiation and indicate the beginning of the ECM form-
ation. After 21 days, ECM dominated in the SEM 
micrographs covering the scaffold pores (Figure 4c). 
This highly developed ECM network demonstrated 
extensive differentiation and good biocompatibility 
between cells and materials, which is essential for 
use in tissue engineering [36]. 
Comparing the nano- and microstructured scaf-
folds, it was demonstrated by a difference in the opti-
cal density obtained by MTT testing and ALP activity 
that the larger surface area of the nanostructured 
scaffold allows better adhesion and provides more 
space for the differentiation of mesenchymal cells 
than in microstructured scaffolds [86]. 
Comparing the adhesion and quantity of human 
osteoblasts cultured on Bio Oss and synthetic bone 
substitute – Nano Bone for 7 days by SEM analysis, a 
significantly higher number of cells with cytoplasmic 
extensions was observed in the presence of Nano 
Bone [87]. 
SEM analysis showed similar results after study-
ing cell morphology and adhesion of mesenchymal 
cells grown for 7 days on PLLA and on nano- and 
micro-HAP/PLLA composite scaffolds. The cells were 
spherical and their number was much higher in the 
presence of nano HAP/PLLA composite scaffold, indi-
cating a superior biocompatibility of that material [88]. 
Hence, there are many scaffolds that exhibit good 
biocompatibility and could replace materials, such as 
golden standard Bio OSS, currently used in bone 
tissue engineering.  
Challenges and future research 
The main requirement for a successful appli-
cation of the scaffold is a high control level of their 
 
Figure 4. Scanning electron microscopy of dental pulp stem cells from deciduous teeth on Albo-Oss (porous hydroxyapatite + PLGA 
composite) scaffold: a) Spherical cells with cytoplasmic extensions indicate good cell adhesion after 7 days in control medium; (b) 
polygonal cells with elongated cytoplasmic extensions pseudopodia indicate very good cell adhesion; fibrous-like organic structures 
point toward beginning of ECM production after 7 days in osteogenic medium; (c) ECM was dominant in the SEM micrographs, 
covering the scaffold and the pores after 21 days in osteogenic medium. 
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micro- and macrostructural properties during pro-
duction process. Mechanical properties of today’s 
composite scaffolds still do not fully satisfy the pro-
perties of natural bone nor succeed in reaching their 
anisotropy [89]. 
Though a wide-range of strategies have been 
employed to produce the ideal scaffold that pos-
sesses the optimum dimensions, porosity, topography 
and mechanical properties, the clinical success of 
such constructs remains elusive [90].  
The rapid development of techniques and fab-
rication tools that have arisen in the recent years 
have signified new beginnings in the field of TE. How-
ever, there are still obstacles in achieving the success 
of the in vitro experiments in an in vivo system. More-
over, the complexity of multiple tissues that form a 
functional organ poses a real challenge to tissue eng-
ineers. Further developments are awaited in reaching 
the goal of creating a completely functional organ, 
thus truly transforming tissue engineering into regen-
erative engineering. 
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NAUČNI RAD 
  BIOLOŠKI ASPEKTI PRIMENE NANOMATERIJALA 
U TKIVNOM INŽENJERSTVU 
Milioni pacijenata širom sveta imaju potrebu za hirurškim procedurama radi reparacije ili 
nadoknade oštećenog tkiva nakon traume ili oboljenja. U cilju rešavanja problema izgub-
ljenog tkiva, tkivno inžinjerstvo glavni akcenat stavlja na tkivnu regeneraciju a ne na za-
menu tkiva, zbog čega postaje predmet sve većeg interesovanja. Matične ćelije i ćelijski 
nosači - visoko porozni biomaterijali, tzv. skafoldi, imaju esencijalnu ulogu u stvaranju 
novog tkiva putem tkivnog inžinjerstva. Ćelijska komponenta je neophodna zbog stvaranja 
i uspostavljanja ekstracelularnog matriksa, dok je skafold zadužen za da odredi oblik novo-
stvorenog tkiva i olakša migraciju ćelija na željeno mesto, njihov rast i diferencijaciju. Ovaj 
pregledni rad opisuje vrste, karakteristike i klasifikaciju matičnih ćelija. Osim toga, uključuje 
i neophodne funkcionalne osobine ćelijskih nosača – biokompatibilnost, biorazgradljivost i 
mehanička svojstva biomaterijala u primeni tkivnog inženjerstva. Takođe, objašnjava raz-
log interesovanja za praktičnu primenu nanomaterijala i nanotehnologije i definiše izazove i 
značaj daljih istraživanja u ovoj oblasti. 
Ključne reči: tkivno inženjerstvo, nanomaterijali, ćelijski nosači (skafoldi), 
matične ćelije, regeneracija tkiva. 
 
 
